 Jacob Lebin
Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Overdose | 6 | 2021 | 296 | 1.540 |
Why?
| | Naloxone | 3 | 2020 | 99 | 1.440 |
Why?
| | Hydroxychloroquine | 2 | 2021 | 55 | 1.420 |
Why?
| | Analgesics, Non-Narcotic | 2 | 2021 | 117 | 1.410 |
Why?
| | Narcotic Antagonists | 3 | 2020 | 139 | 1.360 |
Why?
| | Crataegus | 2 | 2020 | 8 | 0.910 |
Why?
| | Chloroquine | 2 | 2021 | 52 | 0.890 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2021 | 126 | 0.880 |
Why?
| | Syncope | 1 | 2023 | 36 | 0.870 |
Why?
| | Analgesics, Opioid | 3 | 2019 | 783 | 0.850 |
Why?
| | Acetaminophen | 3 | 2021 | 237 | 0.850 |
Why?
| | Methylene Blue | 2 | 2021 | 23 | 0.810 |
Why?
| | Circulating MicroRNA | 1 | 2021 | 24 | 0.760 |
Why?
| | Hand Sanitizers | 1 | 2020 | 2 | 0.730 |
Why?
| | Seizures | 1 | 2023 | 344 | 0.720 |
Why?
| | Dietary Supplements | 2 | 2020 | 458 | 0.690 |
Why?
| | Sodium Chloride | 1 | 2020 | 136 | 0.680 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2021 | 160 | 0.660 |
Why?
| | Anesthetics, Dissociative | 1 | 2019 | 28 | 0.660 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 66 | 0.630 |
Why?
| | Oxymorphone | 1 | 2018 | 3 | 0.630 |
Why?
| | Drug Prescriptions | 1 | 2020 | 241 | 0.620 |
Why?
| | Prescription Drug Diversion | 1 | 2018 | 12 | 0.620 |
Why?
| | Narcotics | 1 | 2018 | 45 | 0.610 |
Why?
| | Ketamine | 1 | 2019 | 92 | 0.600 |
Why?
| | Oxycodone | 1 | 2018 | 44 | 0.600 |
Why?
| | Teratoma | 1 | 2018 | 92 | 0.580 |
Why?
| | Betacoronavirus | 1 | 2020 | 254 | 0.570 |
Why?
| | Nitric Oxide | 1 | 2021 | 832 | 0.530 |
Why?
| | Pandemics | 2 | 2020 | 1335 | 0.510 |
Why?
| | Emergency Service, Hospital | 3 | 2021 | 1829 | 0.510 |
Why?
| | MicroRNAs | 1 | 2021 | 607 | 0.500 |
Why?
| | Alcoholism | 1 | 2021 | 717 | 0.500 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 344 | 0.490 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.490 |
Why?
| | Alcohol Drinking | 1 | 2020 | 650 | 0.490 |
Why?
| | Ovarian Neoplasms | 1 | 2018 | 407 | 0.440 |
Why?
| | Emergency Medical Services | 1 | 2019 | 590 | 0.400 |
Why?
| | Acetylcysteine | 2 | 2021 | 144 | 0.360 |
Why?
| | Sodium Nitrite | 2 | 2021 | 37 | 0.360 |
Why?
| | Hospitalization | 1 | 2019 | 1765 | 0.350 |
Why?
| | Humans | 24 | 2023 | 115739 | 0.350 |
Why?
| | Benzodiazepines | 2 | 2021 | 115 | 0.340 |
Why?
| | Eating | 2 | 2021 | 346 | 0.200 |
Why?
| | Phenobarbital | 1 | 2021 | 17 | 0.200 |
Why?
| | Opioid-Related Disorders | 2 | 2018 | 422 | 0.190 |
Why?
| | Poisons | 1 | 2021 | 21 | 0.190 |
Why?
| | Female | 8 | 2023 | 60016 | 0.180 |
Why?
| | Methemoglobinemia | 1 | 2020 | 13 | 0.180 |
Why?
| | Adult | 7 | 2021 | 30788 | 0.180 |
Why?
| | Antidotes | 1 | 2021 | 135 | 0.170 |
Why?
| | Gold Compounds | 1 | 2019 | 5 | 0.170 |
Why?
| | Cyanates | 1 | 2019 | 4 | 0.170 |
Why?
| | Digoxin | 1 | 2019 | 26 | 0.170 |
Why?
| | Fatal Outcome | 1 | 2020 | 286 | 0.170 |
Why?
| | Cardiotoxicity | 1 | 2019 | 28 | 0.170 |
Why?
| | Potassium Cyanide | 1 | 2019 | 18 | 0.170 |
Why?
| | Acidosis, Lactic | 1 | 2019 | 29 | 0.170 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2019 | 69 | 0.160 |
Why?
| | Insurance Coverage | 1 | 2020 | 204 | 0.160 |
Why?
| | Administration, Intranasal | 1 | 2019 | 75 | 0.160 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2393 | 0.160 |
Why?
| | Intubation, Intratracheal | 1 | 2021 | 215 | 0.160 |
Why?
| | Administration, Intravenous | 1 | 2019 | 126 | 0.160 |
Why?
| | Gold | 1 | 2019 | 107 | 0.160 |
Why?
| | Respiratory Aspiration | 1 | 2018 | 31 | 0.150 |
Why?
| | Vasodilation | 1 | 2021 | 412 | 0.150 |
Why?
| | Prescription Drug Misuse | 1 | 2018 | 38 | 0.150 |
Why?
| | Methadone | 1 | 2019 | 77 | 0.150 |
Why?
| | Commerce | 1 | 2018 | 61 | 0.150 |
Why?
| | Vomiting | 1 | 2018 | 125 | 0.150 |
Why?
| | Plant Extracts | 1 | 2019 | 153 | 0.150 |
Why?
| | Abdominal Pain | 1 | 2018 | 135 | 0.140 |
Why?
| | Male | 8 | 2021 | 56048 | 0.140 |
Why?
| | Respiration, Artificial | 1 | 2021 | 526 | 0.140 |
Why?
| | Comorbidity | 1 | 2020 | 1473 | 0.130 |
Why?
| | Home Care Services | 1 | 2019 | 226 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 242 | 0.130 |
Why?
| | Retrospective Studies | 3 | 2021 | 12633 | 0.130 |
Why?
| | Sex Factors | 1 | 2020 | 1739 | 0.120 |
Why?
| | Treatment Outcome | 2 | 2019 | 9162 | 0.120 |
Why?
| | Chronic Disease | 1 | 2020 | 1598 | 0.120 |
Why?
| | Aged, 80 and over | 3 | 2020 | 6423 | 0.120 |
Why?
| | Age Factors | 1 | 2020 | 2911 | 0.110 |
Why?
| | Suicide | 1 | 2019 | 501 | 0.110 |
Why?
| | Clinical Laboratory Techniques | 1 | 2013 | 87 | 0.100 |
Why?
| | Phenylbutyrates | 1 | 2011 | 21 | 0.090 |
Why?
| | Oncogene Proteins | 1 | 2011 | 53 | 0.090 |
Why?
| | Elbow | 1 | 2011 | 51 | 0.090 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 117 | 0.090 |
Why?
| | Elbow Joint | 1 | 2011 | 60 | 0.090 |
Why?
| | Young Adult | 3 | 2018 | 10518 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4448 | 0.070 |
Why?
| | Parkinson Disease | 1 | 2011 | 325 | 0.070 |
Why?
| | Prospective Studies | 1 | 2018 | 6276 | 0.070 |
Why?
| | Infant | 1 | 2019 | 7978 | 0.060 |
Why?
| | Primary Health Care | 1 | 2013 | 1518 | 0.050 |
Why?
| | United States | 1 | 2018 | 12304 | 0.050 |
Why?
| | Alanine Transaminase | 1 | 2021 | 141 | 0.050 |
Why?
| | Methemoglobin | 1 | 2020 | 19 | 0.050 |
Why?
| | Exercise | 1 | 2011 | 1609 | 0.050 |
Why?
| | Poison Control Centers | 1 | 2021 | 84 | 0.040 |
Why?
| | Iron | 1 | 2021 | 235 | 0.040 |
Why?
| | Plant Roots | 1 | 2019 | 36 | 0.040 |
Why?
| | Databases, Factual | 1 | 2021 | 1139 | 0.030 |
Why?
| | Mortality | 1 | 2018 | 290 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2335 | 0.030 |
Why?
| | Weight Loss | 1 | 2019 | 633 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 17922 | 0.030 |
Why?
| | Liver | 1 | 2021 | 1690 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2013 | 71 | 0.030 |
Why?
| | Aged | 2 | 2021 | 19294 | 0.020 |
Why?
| | Medical Errors | 1 | 2013 | 84 | 0.020 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2011 | 7 | 0.020 |
Why?
| | Peroxiredoxins | 1 | 2011 | 23 | 0.020 |
Why?
| | Evidence-Based Practice | 1 | 2013 | 191 | 0.020 |
Why?
| | Torque | 1 | 2011 | 65 | 0.020 |
Why?
| | Muscular Diseases | 1 | 2011 | 104 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2013 | 287 | 0.020 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 105 | 0.020 |
Why?
| | Muscle Fatigue | 1 | 2011 | 86 | 0.020 |
Why?
| | Isometric Contraction | 1 | 2011 | 152 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2011 | 199 | 0.020 |
Why?
| | Patient Participation | 1 | 2013 | 363 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 354 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2011 | 397 | 0.020 |
Why?
| | Up-Regulation | 1 | 2011 | 820 | 0.020 |
Why?
| | Quality Improvement | 1 | 2013 | 958 | 0.020 |
Why?
| | Proteins | 1 | 2011 | 920 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2011 | 1093 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9136 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2011 | 3914 | 0.010 |
Why?
| | Neurons | 1 | 2011 | 1298 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 3471 | 0.010 |
Why?
| | Child | 1 | 2018 | 18502 | 0.010 |
Why?
| | Middle Aged | 1 | 2018 | 27069 | 0.010 |
Why?
| | Mice | 1 | 2011 | 15052 | 0.010 |
Why?
| | Animals | 1 | 2011 | 32104 | 0.010 |
Why?
|
|
Lebin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|